PHAROVENT financials
A multi-period view of the public annual-account figures reported for PHAROVENT, with comparable measures and links to available source documents.
Company overviewRegistry number
0536820170
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for PHAROVENT
2025 versus 2024
- Operating line
- €166,958
- EBITDA
- €165,264
- Total assets
- €2,839,449
- Equity
- €969,920
-4.9%
-4.9%
-3.1%
+5.8%
EBITDA margin +99% · Equity ratio +34.2%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.